Back | Next |
home / stock / svra / svra message board
Subject | By | Source | When |
---|---|---|---|
* * $SVRA Video Chart 01-02-2020 * * | ClayTrader | investorshub | 01/02/2020 10:10:18 PM |
* * $SVRA Video Chart 12-31-2019 * * | ClayTrader | investorshub | 12/31/2019 10:05:13 PM |
So. We buying calls or puts? 5 strikes. | chrispy2468 | investorshub | 12/31/2019 7:21:55 PM |
We never lose taking profits. | boston127 | investorshub | 12/31/2019 3:41:25 PM |
Whats the offering price? | BoilerRoom | investorshub | 12/31/2019 2:08:19 PM |
You were alerted at 2.30 multiple times bud. | alchemytrader | investorshub | 12/31/2019 12:58:09 PM |
Looks like run is over here. Needs consolidate | BoilerRoom | investorshub | 12/31/2019 12:54:13 PM |
I did the same damn thing: | Hercules1 | investorshub | 12/31/2019 4:29:06 AM |
$$Nice move up today. Congrats. | williamssc | investorshub | 12/31/2019 3:40:37 AM |
I got it - sold too soon. | boston127 | investorshub | 12/31/2019 3:29:35 AM |
Their latest presentation is worth a listen http://wsw.com/webcast/evercore4/svra/index.aspx[/ | Biobonic | investorshub | 12/30/2019 11:11:01 PM |
http://ih.advfn.com/stock-market/NASDAQ/savara-$SVRA/stock-news/81434794/current-report-filing-8-k | north40000 | investorshub | 12/30/2019 10:51:49 PM |
over 6 buks now | Rocketred | investorshub | 12/30/2019 10:30:12 PM |
So far this evening, the $3.50 area is | davidsson10 | investorshub | 12/30/2019 10:15:44 PM |
Go to the presentations on $SVRA website | Biobonic | investorshub | 12/30/2019 9:39:47 PM |
* * $SVRA Video Chart 12-30-2019 * * | ClayTrader | investorshub | 12/30/2019 9:36:06 PM |
PoemStone: $SVRA a small pullback after hours. | PoemStone | investorshangout | 12/30/2019 9:25:59 PM |
znewcar1: SVRA 183% v53M c4.91 f41M H5.2 gapped up 4.6 S@3.25 then EOD push to | znewcar1 | investorshangout | 12/30/2019 9:09:04 PM |
Wow | steez | investorshub | 12/30/2019 8:56:09 PM |
I think $5 break is coming right up. | Hercules1 | investorshub | 12/30/2019 8:46:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Savara’s Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP Company to Host Industry Theater on Pulmonary Alveolar Proteinosis (PAP) with Two World-Renowned Experts Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage ...
Remains On-Track to Report Top Line Data from the Pivotal Phase 3 IMPALA-2 Trial by End of 2Q 2024 48-week placebo-controlled trial is evaluating molgramostim nebulizer solution (molgramostim), a novel inhaled biologic, for the treatment of autoimmune Pulmonary Alveolar Proteinosis (aPAP)...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 14, 2024 at 5:00am PT/8:00am ET. A live web...